| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 2252403-56-6 | 6-Fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-[4-methyl-2-(1-methylethyl)-3-pyridinyl]-4-[(2S)-2-methyl-4-(1-oxo-2-propen-1-yl)-1-piperazinyl]-pyrido[2,3-d]pyrimidin-2(1H)-one | C30H30F2N6O3 |
| 2252403-82-8 | 7-chloro-6-fluoro-1-(2-isopropyl-4-methylpyridin-3-yl)pyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione | C16H14ClFN4O2 |
| 2252446-68-5 | Moxifloxacin Impurity 7 Hydrochloride | C22H28ClN3O5 |
| 2252446-69-6 | Moxifloxacin EP Impurity D | C21H24FN3O4 .HCl |
| 2252446-70-9 | Moxifloxacin EP Impurity C HCl | C22H27ClFN3O4 |
| 2252446-71-0 | 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-hydroxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid hydrochloride (1:1) | C20H22FN3O4.HCl |
| 2252493-06-2 | DBCO-SH | C21H20N2O2S |
| 2253194-12-4 | (2S)-1-[2-[(2S)-2-Cyano-1-pyrrolidinyl]-2-oxoethyl]-2-pyrrolidinecarboxamide | C12H18N4O2 |
| 2253631-32-0 | 1-(Fluoromethyl)-2-oxabicyclo[2.1.1]hexane-4-carboxylic acid | C7H9FO3 |
| 2253964-85-9 | Linagliptin Impurity 5 | C25H28N8O2 |
| 2253964-98-4 | N-Depiperidin-3-Amine Linagliptin Dimer | C45H44N14O4 |
| 2253969-12-7 | 3,9-Diamino-benzo[1,2-b:4,5-b']bis[1]benzothiophene-5,5,11,11-tetraoxide | C18H12N2O4S2 |
| 2254444-59-0 | (2S,3S,4R,5S,6R)-2-(3-Chloro-4-methylphenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triyl triacetate | C19H23ClO7S |
| 2254447-02-2 | Benzo[d][1,3]dioxole-5-carbonyl fluoride | C8H5FO3 |
| 2254541-79-0 | Crisaborole Dimer Impurity | C28H20N2O4 |
| 2256739-22-5 | Posaconazole impurity 23 | C28H28F4N6O3 |
| 2257421-79-5 | Progesterone EP Impurity G | C27H38O2 |
| 2257421-80-8 | Progesterone EP Impurity L | C22H30O2 |
| 2259708-00-2 | Sacubitril-(2R,4R)-Isomer | C24H29NO5 |
| 2259884-03-0 | Mazdutide | C207H317N45O65 |
| 2261008-21-1 | Naphtho[2,3-b]benzofuran-1-ylboronic acid | C16H11BO3 |
| 2265214-89-7 | Canagliflozin Impurity 70 | C18H14BrFS |
| 2265924-59-0 | 4-Chloro-1-phenyldibenzofuran | C18H11ClO |
| 2269476-12-0 | 5,8-Dibromo-6,7-difluoro-2-((2-hexyldecyl)oxy)quinoxaline | C24H34Br2F2N2O |
| 2269476-13-1 | PTQ10 | C34H54Br2F2N2OSSn2 |
| 2270831-00-8 | 2-(4-methoxyphenyl)-2-(5-((tosyloxy)imino)thiophen-2(5H)-ylidene)acetonitrile | C20H16N2O4S2 |
| 2271228-51-2 | Acetamide Baricitinib Impurity | C16H19N7O3S |
| 2271228-52-3 | Baricitinib Acetic Acid Impurity | C16H18N6O4S |
| 2271248-78-1 | Dapagliflozin Impurity 14 | C21H25ClO6 |
| 2271411-87-9 | Ibandronate Impurity 3 | C9H19NO8P2 .4Na |
| 2271443-87-7 | Carbazochrome Impurity 7 | C9H9NO4S |
| 2274791-00-1 | 2-chloronaphtho[1,2-b]benzofuran | C16H9ClO |
| 2276538-67-9 | Bortezomib Impurity 12 | C19H22N4O2 |
| 2276678-27-2 | Pitavastatin Impurity 18 Sodium Salt | C25H23FNO5 .Na |
| 2278296-49-2 | tert-Butyl ((3R,4S)-4-(difluoromethyl)pyrrolidin-3-yl)carbamate | C10H18F2N2O2 |
| 2279114-27-9 | Linagliptin impurity KH-3 | C30H39N7O6 |
| 2279137-61-8 | 2-([1,1'-Biphenyl]-2-yl)-4-([1,1'-biphenyl]-4-yl)-6-chloro-1,3,5-triazine | C27H18ClN3 |
| 2280088-44-8 | Cinitapride Impurity 8 | C15H22N4O6S |
| 2286278-51-9 | Mycophenolate Mofetil EP Impurity C | C23H31NO7 |
| 2287283-91-2 | 1-(2-Bromoethyl)-3,3-difluoropyrrolidine | C6H11Br2F2N |
| 2287318-89-0 | 4-(Trifluoromethyl)-2-oxabicyclo[2.1.1]hexane-1-carboxylic acid | C7H7F3O3 |
| 2287955-97-7 | tert-Butyl 3,3-difluoro-4-formylpyrrolidine-1-carboxylate | C10H15F2NO3 |
| 2290571-51-4 | Rosuvastatin EP Impurity K | C22H26FN3O5S |
| 2291328-15-7 | Trabectedin intermediate M19 | C43H45N3O6 |
| 2295925-90-3 | (R)-N-Benzyl-2-(3-benzylureido)-3-methoxypropanamide | C19H23N3O3 |
| 2296729-00-3 | Sotorasib | C30H30F2N6O3 |
| 2300968-85-6 | Macitentan Impurity 39 | C19H22N6O4S |
| 2300968-87-8 | Macitentan Impurity 6 | C19H21BrN6O4S |
| 2301113-15-3 | Roxadustat Aziridine | C19H16N2O5 |
| 2303611-62-1 | 5-([1,1'-Biphenyl]-3-yl)-5,8-dihydroindolo[2,3-c]carbazole | C30H20N2 |